With Thermo Fisher Scientific as your delivery solutions partner, you can have confidence from clinical research, development to the commercialization of your nucleic acid therapeutics. Invitrogen Vivofectamine™ Delivery Solutions offer high-performance lipid nanoparticles (LNP) with proven safety, organ specificity, and efficacy, as well as a broad IP portfolio with chemical diversity to empower your innovation. With over 30 years of experience providing comprehensive and seamless delivery technologies, we are the partner you can count on to help enable your next breakthrough RNA-based therapy.
“Vivofectamine was easy to formulate and was effective in vivo. We evaluated model antigen delivery with Vivofectamine in mice and found induction of both T and B cell responses.”
Immunologist from leading US biopharmaceutical company
For Research Use Only. Not for use in diagnostic procedures.